Inhibitions of ERK1/2 and/or PI3K/Akt pathways by CD would suppress tumor cell proliferation and tumor growth, which have been well investigated and illustrated in RCC [44] and bladder cancer cell lines [52]. Here, AKT1 is linked to neoplasm.